BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shen Q, Cicinnati VR, Zhang X, Iacob S, Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G. Role of microRNA-199a-5p and discoidin domain receptor 1 in human hepatocellular carcinoma invasion. Mol Cancer. 2010;9:227. [PMID: 20799954 DOI: 10.1186/1476-4598-9-227] [Cited by in Crossref: 123] [Cited by in F6Publishing: 128] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhang J, Zhang D, Wu GQ, Feng ZY, Zhu SM. Propofol inhibits the adhesion of hepatocellular carcinoma cells by upregulating microRNA-199a and downregulating MMP-9 expression. Hepatobiliary Pancreat Dis Int 2013;12:305-9. [PMID: 23742776 DOI: 10.1016/s1499-3872(13)60048-x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 5.1] [Reference Citation Analysis]
2 de Antonellis P, Liguori L, Falanga A, Carotenuto M, Ferrucci V, Andolfo I, Marinaro F, Scognamiglio I, Virgilio A, De Rosa G, Galeone A, Galdiero S, Zollo M. MicroRNA 199b-5p delivery through stable nucleic acid lipid particles (SNALPs) in tumorigenic cell lines. Naunyn-Schmiedeberg's Arch Pharmacol 2013;386:287-302. [DOI: 10.1007/s00210-013-0837-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
3 Xie R, Wang X, Qi G, Wu Z, Wei R, Li P, Zhang D. DDR1 enhances invasion and metastasis of gastric cancer via epithelial-mesenchymal transition. Tumour Biol 2016;37:12049-59. [PMID: 27179963 DOI: 10.1007/s13277-016-5070-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
4 Wang S, Fu Y, Kuerban K, Liu J, Huang X, Pan D, Chen H, Zhu Y, Ye L. Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer. Front Immunol 2022;13:933165. [DOI: 10.3389/fimmu.2022.933165] [Reference Citation Analysis]
5 Hsu CY, Hsieh TH, Tsai CF, Tsai HP, Chen HS, Chang Y, Chuang HY, Lee JN, Hsu YL, Tsai EM. miRNA-199a-5p regulates VEGFA in endometrial mesenchymal stem cells and contributes to the pathogenesis of endometriosis. J Pathol 2014;232:330-43. [PMID: 24155090 DOI: 10.1002/path.4295] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 9.5] [Reference Citation Analysis]
6 Kim BK, Kim I, Lee AR, Yoo HI, Yoon SK. Mouse-specific up-regulation of Ccnb1 expression by miR-199a-5p in keratinocyte. FEBS Open Bio 2016;6:1131-40. [PMID: 27833853 DOI: 10.1002/2211-5463.12133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
7 Wu SC, Hsiao HF, Ho ML, Hung YL, Chang JK, Wang GJ, Wang CZ. Suppression of discoidin domain receptor 1 expression enhances the chondrogenesis of adipose-derived stem cells. Am J Physiol Cell Physiol 2015;308:C685-96. [PMID: 25673773 DOI: 10.1152/ajpcell.00398.2014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
8 Henriet E, Sala M, Abou Hammoud A, Tuariihionoa A, Di Martino J, Ros M, Saltel F. Multitasking discoidin domain receptors are involved in several and specific hallmarks of cancer. Cell Adh Migr 2018;12:363-77. [PMID: 29701112 DOI: 10.1080/19336918.2018.1465156] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
9 He XJ, Ma YY, Yu S, Jiang XT, Lu YD, Tao L, Wang HP, Hu ZM, Tao HQ. Up-regulated miR-199a-5p in gastric cancer functions as an oncogene and targets klotho. BMC Cancer. 2014;14:218. [PMID: 24655788 DOI: 10.1186/1471-2407-14-218] [Cited by in Crossref: 56] [Cited by in F6Publishing: 65] [Article Influence: 7.0] [Reference Citation Analysis]
10 He H, Wang L, Zhou W, Zhang Z, Wang L, Xu S, Wang D, Dong J, Tang C, Tang H, Yi X, Ge J. MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. PLoS One 2015;10:e0125672. [PMID: 25938468 DOI: 10.1371/journal.pone.0125672] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
11 Yi H, Liang B, Jia J, Liang N, Xu H, Ju G, Ma S, Liu X. Differential roles of miR-199a-5p in radiation-induced autophagy in breast cancer cells. FEBS Lett 2013;587:436-43. [PMID: 23337876 DOI: 10.1016/j.febslet.2012.12.027] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 6.3] [Reference Citation Analysis]
12 Huang L, Lin JX, Yu YH, Zhang MY, Wang HY, Zheng M. Downregulation of six microRNAs is associated with advanced stage, lymph node metastasis and poor prognosis in small cell carcinoma of the cervix. PLoS One 2012;7:e33762. [PMID: 22438992 DOI: 10.1371/journal.pone.0033762] [Cited by in Crossref: 73] [Cited by in F6Publishing: 81] [Article Influence: 7.3] [Reference Citation Analysis]
13 Matà R, Palladino C, Nicolosi ML, Lo Presti AR, Malaguarnera R, Ragusa M, Sciortino D, Morrione A, Maggiolini M, Vella V, Belfiore A. IGF-I induces upregulation of DDR1 collagen receptor in breast cancer cells by suppressing MIR-199a-5p through the PI3K/AKT pathway. Oncotarget 2016;7:7683-700. [PMID: 26655502 DOI: 10.18632/oncotarget.6524] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 8.2] [Reference Citation Analysis]
14 Vella V, Malaguarnera R, Nicolosi ML, Morrione A, Belfiore A. Insulin/IGF signaling and discoidin domain receptors: An emerging functional connection. Biochim Biophys Acta Mol Cell Res 2019;1866:118522. [PMID: 31394114 DOI: 10.1016/j.bbamcr.2019.118522] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
15 Suzuki T, Mizutani K, Minami A, Nobutani K, Kurita S, Nagino M, Shimono Y, Takai Y. Suppression of the TGF-β1-induced protein expression of SNAI1 and N-cadherin by miR-199a. Genes Cells 2014;19:667-75. [PMID: 25041364 DOI: 10.1111/gtc.12166] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
16 Wei D, Shen B, Wang W, Zhou Y, Yang X, Lu G, Yang J, Shao Y. MicroRNA‑199a‑5p functions as a tumor suppressor in oral squamous cell carcinoma via targeting the IKKβ/NF‑κB signaling pathway. Int J Mol Med 2019;43:1585-96. [PMID: 30720059 DOI: 10.3892/ijmm.2019.4083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
17 Shi C, Xu X. MiR-670-5p induces cell proliferation in hepatocellular carcinoma by targeting PROX1. Biomed Pharmacother 2016;77:20-6. [PMID: 26796260 DOI: 10.1016/j.biopha.2015.07.030] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
18 Aranda JF, Canfrán-Duque A, Goedeke L, Suárez Y, Fernández-Hernando C. The miR-199-dynamin regulatory axis controls receptor-mediated endocytosis. J Cell Sci 2015;128:3197-209. [PMID: 26163491 DOI: 10.1242/jcs.165233] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
19 Dat VHX, Nhung BTH, Chau NNB, Cuong PH, Hieu VD, Linh NTM, Quoc NB. Identification of potential microRNA groups for the diagnosis of hepatocellular carcinoma (HCC) using microarray datasets and bioinformatics tools. Heliyon 2022;8:e08987. [PMID: 35243101 DOI: 10.1016/j.heliyon.2022.e08987] [Reference Citation Analysis]
20 Sun Z, Meng C, Wang S, Zhou N, Guan M, Bai C, Lu S, Han Q, Zhao RC. MicroRNA-1246 enhances migration and invasion through CADM1 in hepatocellular carcinoma. BMC Cancer 2014;14:616. [PMID: 25159494 DOI: 10.1186/1471-2407-14-616] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 6.9] [Reference Citation Analysis]
21 Hashemi Gheinani A, Burkhard FC, Rehrauer H, Aquino Fournier C, Monastyrskaya K. MicroRNA MiR-199a-5p regulates smooth muscle cell proliferation and morphology by targeting WNT2 signaling pathway. J Biol Chem 2015;290:7067-86. [PMID: 25596533 DOI: 10.1074/jbc.M114.618694] [Cited by in Crossref: 46] [Cited by in F6Publishing: 21] [Article Influence: 6.6] [Reference Citation Analysis]
22 Zuberi M, Khan I, Gandhi G, Ray PC, Saxena A. The conglomeration of diagnostic, prognostic and therapeutic potential of serum miR-199a and its association with clinicopathological features in epithelial ovarian cancer. Tumour Biol 2016;37:11259-66. [PMID: 26951510 DOI: 10.1007/s13277-016-4993-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
23 Zhang S, Zhou Y, Wang Y, Wang Z, Xiao Q, Zhang Y, Lou Y, Qiu Y, Zhu F. The mechanistic, diagnostic and therapeutic novel nucleic acids for hepatocellular carcinoma emerging in past score years. Brief Bioinform 2021;22:1860-83. [PMID: 32249290 DOI: 10.1093/bib/bbaa023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Chou ST, Peng HY, Mo KC, Hsu YM, Wu GH, Hsiao JR, Lin SF, Wang HD, Shiah SG. MicroRNA-486-3p functions as a tumor suppressor in oral cancer by targeting DDR1. J Exp Clin Cancer Res 2019;38:281. [PMID: 31253192 DOI: 10.1186/s13046-019-1283-z] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
25 Dai BH, Geng L, Wang Y, Sui CJ, Xie F, Shen RX, Shen WF, Yang JM. microRNA-199a-5p protects hepatocytes from bile acid-induced sustained endoplasmic reticulum stress. Cell Death Dis. 2013;4:e604. [PMID: 23598416 DOI: 10.1038/cddis.2013.134] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 5.3] [Reference Citation Analysis]
26 Li C, Li JF, Cai Q, Qiu QQ, Yan M, Liu BY, Zhu ZG. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Ann Surg Oncol. 2013;20 Suppl 3:S397-S405. [PMID: 22956063 DOI: 10.1245/s10434-012-2600-3] [Cited by in Crossref: 36] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
27 Ma S, Jia W, Ni S. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1. Biochemical and Biophysical Research Communications 2018;497:181-6. [DOI: 10.1016/j.bbrc.2018.02.051] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
28 Wu A, Chen Y, Liu Y, Lai Y, Liu D. miR-199b-5p inhibits triple negative breast cancer cell proliferation, migration and invasion by targeting DDR1. Oncol Lett 2018;16:4889-96. [PMID: 30250555 DOI: 10.3892/ol.2018.9255] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
29 Elkamhawy A, Lu Q, Nada H, Woo J, Quan G, Lee K. The Journey of DDR1 and DDR2 Kinase Inhibitors as Rising Stars in the Fight Against Cancer. Int J Mol Sci 2021;22:6535. [PMID: 34207360 DOI: 10.3390/ijms22126535] [Reference Citation Analysis]
30 Callegari E, Gramantieri L, Domenicali M, D’Abundo L, Sabbioni S, Negrini M. MicroRNAs in liver cancer: a model for investigating pathogenesis and novel therapeutic approaches. Cell Death Differ. 2015;22:46-57. [PMID: 25190143 DOI: 10.1038/cdd.2014.136] [Cited by in Crossref: 85] [Cited by in F6Publishing: 93] [Article Influence: 10.6] [Reference Citation Analysis]
31 Xu Y, Chai B, Wang X, Wu Z, Gu Z, Liu X, Zhao Y, Chen T, Ma Z, Sun Q. miRNA-199a-5p/SLC2A1 axis regulates glucose metabolism in non-small cell lung cancer. J Cancer 2022;13:2352-61. [PMID: 35517408 DOI: 10.7150/jca.67990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Zhang S, Liu L, Wang R, Tuo H, Guo Y, Yi L, Wang J, Wang D. MiR-199a-5p promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and eNOS. Arch Virol 2013;158:2443-52. [PMID: 23760629 DOI: 10.1007/s00705-013-1744-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
33 Belfiore A, Malaguarnera R, Nicolosi ML, Lappano R, Ragusa M, Morrione A, Vella V. A novel functional crosstalk between DDR1 and the IGF axis and its relevance for breast cancer. Cell Adh Migr 2018;12:305-14. [PMID: 29486622 DOI: 10.1080/19336918.2018.1445953] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
34 Nothnick WB. Non-coding RNAs in Uterine Development, Function and Disease. Adv Exp Med Biol 2016;886:171-89. [PMID: 26659492 DOI: 10.1007/978-94-017-7417-8_9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
35 Liu L, Lu L, Zheng A, Xie J, Xue Q, Wang F, Wang X, Zhou H, Tong X, Li Y, Zhu X, Wu G. MiR-199a-5p and let-7c cooperatively inhibit migration and invasion by targeting MAP4K3 in hepatocellular carcinoma. Oncotarget 2017;8:13666-77. [PMID: 28099144 DOI: 10.18632/oncotarget.14623] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
36 Gheinani AH, Burkhard FC, Monastyrskaya K. Deciphering microRNA code in pain and inflammation: lessons from bladder pain syndrome. Cell Mol Life Sci 2013;70:3773-89. [PMID: 23463234 DOI: 10.1007/s00018-013-1275-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
37 Nothnick WB. MicroRNAs and Endometriosis: Distinguishing Drivers from Passengers in Disease Pathogenesis. Semin Reprod Med 2017;35:173-80. [PMID: 28212593 DOI: 10.1055/s-0037-1599089] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 6.6] [Reference Citation Analysis]
38 Zhang L, Cao H, Gu G, Hou D, You Y, Li X, Chen Y, Jiao G. Exosomal MiR-199a-5p Inhibits Tumorigenesis and Angiogenesis by Targeting VEGFA in Osteosarcoma. Front Oncol 2022;12:884559. [DOI: 10.3389/fonc.2022.884559] [Reference Citation Analysis]
39 Khare S, Zhang Q, Ibdah JA. Epigenetics of hepatocellular carcinoma: Role of microRNA. World J Gastroenterol 2013; 19(33): 5439-5445 [PMID: 24023486 DOI: 10.3748/wjg.v19.i33.5439] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 48] [Article Influence: 6.7] [Reference Citation Analysis]
40 Yu X, Li Z, Chan MT, Wu WK. microRNA deregulation in keloids: an opportunity for clinical intervention? Cell Prolif 2015;48:626-30. [PMID: 26486103 DOI: 10.1111/cpr.12225] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
41 Hanin G, Soreq H. Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes. Front Mol Neurosci 2011;4:28. [PMID: 22007158 DOI: 10.3389/fnmol.2011.00028] [Cited by in Crossref: 18] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
42 Jiang W, Zhang L, Guo Q, Wang H, Ma M, Sun J, Chen C. Identification of the Pathogenic Biomarkers for Hepatocellular Carcinoma Based on RNA-seq Analyses. Pathol Oncol Res 2019;25:1207-13. [PMID: 30680535 DOI: 10.1007/s12253-019-00596-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
43 Morishita A, Oura K, Tadokoro T, Fujita K, Tani J, Masaki T. MicroRNAs in the Pathogenesis of Hepatocellular Carcinoma: A Review. Cancers (Basel) 2021;13:514. [PMID: 33572780 DOI: 10.3390/cancers13030514] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
44 Chi Q, Geng X, Xu K, Wang C, Zhao H. Potential targets and molecular mechanism of miR-331-3p in hepatocellular carcinoma identified by weighted gene coexpression network analysis. Biosci Rep 2020;40:BSR20200124. [PMID: 32537629 DOI: 10.1042/BSR20200124] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Sharifian M, Baharvand P, Moayyedkazemi A. Liver Cancer: New Insights into Surgical and Nonsurgical Treatments. CCTR 2021;17:197-206. [DOI: 10.2174/1573394717666210219104201] [Reference Citation Analysis]
46 Zhong J, Huang R, Su Z, Zhang M, Xu M, Gong J, Chen N, Zeng H, Chen X, Zhou Q. Downregulation of miR-199a-5p promotes prostate adeno-carcinoma progression through loss of its inhibition of HIF-1α. Oncotarget 2017;8:83523-38. [PMID: 29137361 DOI: 10.18632/oncotarget.18315] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
47 Valiathan RR, Marco M, Leitinger B, Kleer CG, Fridman R. Discoidin domain receptor tyrosine kinases: new players in cancer progression. Cancer Metastasis Rev. 2012;31:295-321. [PMID: 22366781 DOI: 10.1007/s10555-012-9346-z] [Cited by in Crossref: 221] [Cited by in F6Publishing: 213] [Article Influence: 22.1] [Reference Citation Analysis]
48 Zhou G, Lu M, Chen J, Li C, Zhang J, Chen J, Shi X, Wu S. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma. Tumour Biol 2015;36:8845-52. [PMID: 26069101 DOI: 10.1007/s13277-015-3421-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 4.4] [Reference Citation Analysis]
49 Liu Z, Wang T, Zhang Z, Tang S, Feng S, Yue M, Hu M, Xuan L, Chen Y. Survivin downregulation using siRNA nanoliposomes inhibits cell proliferation and promotes the apoptosis of MHCC-97H hepatic cancer cells: An in vitro and in vivo study. Oncol Lett 2017;13:2723-30. [PMID: 28454458 DOI: 10.3892/ol.2017.5754] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
50 Weidle UH, Nopora A. Identification of MicroRNAs With In Vivo Efficacy in Multiple Myeloma-related Xenograft Models. Cancer Genomics Proteomics 2020;17:321-34. [PMID: 32576578 DOI: 10.21873/cgp.20192] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
51 Atanasov J, Groher F, Weigand JE, Suess B. Design and implementation of a synthetic pre-miR switch for controlling miRNA biogenesis in mammals. Nucleic Acids Res 2017;45:e181. [PMID: 29036355 DOI: 10.1093/nar/gkx858] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
52 Dai L, Gu L, Di W. MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKβ/NF-κB pathway and reduced interleukin-8 expression. Mol Hum Reprod 2012;18:136-45. [PMID: 21989168 DOI: 10.1093/molehr/gar066] [Cited by in Crossref: 71] [Cited by in F6Publishing: 73] [Article Influence: 6.5] [Reference Citation Analysis]
53 Wang S, Cao KE, He Q, Yin Z, Zhou J. miR-199a-5p induces cell invasion by suppressing E-cadherin expression in cutaneous squamous cell carcinoma. Oncol Lett 2016;12:97-101. [PMID: 27347107 DOI: 10.3892/ol.2016.4602] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
54 Ravindran F, Koroth J, Manjunath M, Narayan S, Choudhary B. Curcumin derivative ST09 modulates the miR-199a-5p/DDR1 axis and regulates proliferation and migration in ovarian cancer cells. Sci Rep 2021;11:23025. [PMID: 34837026 DOI: 10.1038/s41598-021-02454-1] [Reference Citation Analysis]
55 Li M, Luan L, Liu Q, Liu Y, Lan X, Li Z, Liu W. MiRNA-199a-5p Protects Against Cerebral Ischemic Injury by Down-Regulating DDR1 in Rats. World Neurosurgery 2019;131:e486-94. [DOI: 10.1016/j.wneu.2019.07.203] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
56 Chan YC, Roy S, Huang Y, Khanna S, Sen CK. The microRNA miR-199a-5p down-regulation switches on wound angiogenesis by derepressing the v-ets erythroblastosis virus E26 oncogene homolog 1-matrix metalloproteinase-1 pathway. J Biol Chem 2012;287:41032-43. [PMID: 23060436 DOI: 10.1074/jbc.M112.413294] [Cited by in Crossref: 55] [Cited by in F6Publishing: 29] [Article Influence: 5.5] [Reference Citation Analysis]
57 Krazinski BE, Kiewisz J, Sliwinska-Jewsiewicka A, Kowalczyk AE, Grzegrzolka J, Godlewski J, Kwiatkowski P, Dziegiel P, Kmiec Z. Altered Expression of DDR1 in Clear Cell Renal Cell Carcinoma Correlates With miR-199a/b-5p and Patients' Outcome. Cancer Genomics Proteomics 2019;16:179-93. [PMID: 31018949 DOI: 10.21873/cgp.20124] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
58 Sun J, Lu H, Wang X, Jin H. MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. ScientificWorldJournal 2013;2013:924206. [PMID: 23431261 DOI: 10.1155/2013/924206] [Cited by in Crossref: 37] [Cited by in F6Publishing: 53] [Article Influence: 4.1] [Reference Citation Analysis]
59 Zhang Y, Fan KJ, Sun Q, Chen AZ, Shen WL, Zhao ZH, Zheng XF, Yang X. Functional screening for miRNAs targeting Smad4 identified miR-199a as a negative regulator of TGF-β signalling pathway. Nucleic Acids Res. 2012;40:9286-9297. [PMID: 22821565 DOI: 10.1093/nar/gks667] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
60 Qu D, Yang Y, Huang X. miR-199a-5p promotes proliferation and metastasis and epithelial-mesenchymal transition through targeting PIAS3 in cervical carcinoma. J Cell Biochem 2019;120:13562-72. [PMID: 30937952 DOI: 10.1002/jcb.28631] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
61 Matada GSP, Das A, Dhiwar PS, Ghara A. DDR1 and DDR2: a review on signaling pathway and small molecule inhibitors as an anticancer agent. Med Chem Res 2021;30:535-51. [DOI: 10.1007/s00044-020-02694-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
62 Zhang Q, Pu R, Du Y, Han Y, Su T, Wang H, Cao G. Non-coding RNAs in hepatitis B or C-associated hepatocellular carcinoma: potential diagnostic and prognostic markers and therapeutic targets. Cancer Lett. 2012;321:1-12. [PMID: 22425745 DOI: 10.1016/j.canlet.2012.03.011] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
63 Zhu X, Yao M, Zhang B, Zhu C, Zhu F, Shen T, Fang C. Biological information and functional analysis reveal the role of discoidin domain receptor 1 in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol 2021;131:221-30. [PMID: 33309038 DOI: 10.1016/j.oooo.2020.10.010] [Reference Citation Analysis]
64 Van Keuren-Jensen KR, Malenica I, Courtright AL, Ghaffari LT, Starr AP, Metpally RP, Beecroft TA, Carlson EW, Kiefer JA, Pockros PJ. microRNA changes in liver tissue associated with fibrosis progression in patients with hepatitis C. Liver Int. 2016;36:334-343. [PMID: 26189820 DOI: 10.1111/liv.12919] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 3.0] [Reference Citation Analysis]
65 Morishita A, Masaki T. miRNA in hepatocellular carcinoma. Hepatol Res. 2015;45:128-141. [PMID: 25040738 DOI: 10.1111/hepr.12386] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 8.6] [Reference Citation Analysis]
66 Papaconstantinou I, Karakatsanis A, Gazouli M, Polymeneas G, Voros D. The role of microRNAs in liver cancer. Eur J Gastroenterol Hepatol 2012;24:223-8. [PMID: 22228372 DOI: 10.1097/MEG.0b013e3283505063] [Cited by in Crossref: 28] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
67 Lee JM, Heo MJ, Lee CG, Yang YM, Kim SG. Increase of miR-199a-5p by protoporphyrin IX, a photocatalyzer, directly inhibits E2F3, sensitizing mesenchymal tumor cells to anti-cancer agents. Oncotarget 2015;6:3918-31. [PMID: 25714015 DOI: 10.18632/oncotarget.2928] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
68 Wei D, Wang W, Shen B, Zhou Y, Yang X, Lu G, Yang J, Shao Y. MicroRNA‑199a‑5p suppresses migration and invasion in oral squamous cell carcinoma through inhibiting the EMT‑related transcription factor SOX4. Int J Mol Med 2019;44:185-95. [PMID: 31059001 DOI: 10.3892/ijmm.2019.4174] [Cited by in Crossref: 4] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
69 Chai S, Ma S. Clinical implications of microRNAs in liver cancer stem cells. Chin J Cancer 2013;32:419-26. [PMID: 23668930 DOI: 10.5732/cjc.013.10038] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
70 Ashrafizadeh M, Ahmadi Z, Farkhondeh T, Samarghandian S. Anti-tumor Activity of Propofol: A Focus on MicroRNAs. Curr Cancer Drug Targets 2020;20:104-14. [PMID: 31657687 DOI: 10.2174/1568009619666191023100046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
71 Liu C, Xing M, Wang L, Zhang K. miR-199a-3p downregulation in thyroid tissues is associated with invasion and metastasis of papillary thyroid carcinoma. British Journal of Biomedical Science 2017;74:90-4. [DOI: 10.1080/09674845.2016.1264705] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
72 He Y, Xiong L, Gao X, Hai M, Liu Y, Wang G, Chen G, Shuai J, Jiao Y, Zhang X, Liu R, Liu L. Morphological quantification of proliferation-to-invasion transition in tumor spheroids. Biochim Biophys Acta Gen Subj 2020;1864:129460. [PMID: 31672655 DOI: 10.1016/j.bbagen.2019.129460] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
73 Bronte F, Bronte G, Fanale D, Caruso S, Bronte E, Bavetta MG, Fiorentino E, Rolfo C, Bazan V, Di Marco V, Russo A. HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma. Crit Rev Oncol Hematol 2016;97:312-21. [PMID: 26603462 DOI: 10.1016/j.critrevonc.2015.09.007] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
74 Ma L, Chua MS, Andrisani O, So S. Epigenetics in hepatocellular carcinoma: an update and future therapy perspectives. World J Gastroenterol 2014;20:333-45. [PMID: 24574704 DOI: 10.3748/wjg.v20.i2.333] [Cited by in CrossRef: 66] [Cited by in F6Publishing: 61] [Article Influence: 8.3] [Reference Citation Analysis]
75 Ben Arfi K, Schneider C, Bennasroune A, Bouland N, Wolak-thierry A, Collin G, Le CC, Toussaint K, Hachet C, Lehrter V, Dedieu S, Bouché O, Morjani H, Boulagnon-rombi C, Appert-collin A. Discoidin Domain Receptor 1 Expression in Colon Cancer: Roles and Prognosis Impact. Cancers 2022;14:928. [DOI: 10.3390/cancers14040928] [Reference Citation Analysis]
76 Wang H, Gao H, Duan S, Song X. Inhibition of microRNA-199a-5p reduces the replication of HCV via regulating the pro-survival pathway. Virus Res 2015;208:7-12. [PMID: 26027911 DOI: 10.1016/j.virusres.2015.05.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
77 Cristóbal I, Santos A, Rubio J, Rojo F, García-Foncillas J. Comment on "miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition". Br J Cancer 2021;125:618-9. [PMID: 34012034 DOI: 10.1038/s41416-021-01433-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
78 Huang J, Zhang L, Wan D, Zhou L, Zheng S, Lin S, Qiao Y. Extracellular matrix and its therapeutic potential for cancer treatment. Signal Transduct Target Ther 2021;6:153. [PMID: 33888679 DOI: 10.1038/s41392-021-00544-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
79 Wu L, Cai C, Wang X, Liu M, Li X, Tang H. MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett. 2011;585:1322-1330. [PMID: 21482222 DOI: 10.1016/j.febslet.2011.03.067] [Cited by in Crossref: 113] [Cited by in F6Publishing: 110] [Article Influence: 10.3] [Reference Citation Analysis]
80 Wang C, Ba X, Guo Y, Sun D, Jiang H, Li W, Huang Z, Zhou G, Wu S, Zhang J, Chen J. MicroRNA-199a-5p promotes tumour growth by dual-targeting PIAS3 and p27 in human osteosarcoma. Sci Rep 2017;7:41456. [PMID: 28120918 DOI: 10.1038/srep41456] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 4.2] [Reference Citation Analysis]
81 Ngai D, Mohabeer AL, Mao A, Lino M, Bendeck MP. Stiffness-Responsive Feedback Autoregulation of DDR1 Expression is Mediated by a DDR1-YAP/TAZ Axis. Matrix Biol 2022:S0945-053X(22)00070-1. [PMID: 35562016 DOI: 10.1016/j.matbio.2022.05.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
82 Oh S, Seo M, Choi JS, Joo CK, Lee SK. MiR-199a/b-5p Inhibits Lymphangiogenesis by Targeting Discoidin Domain Receptor 1 in Corneal Injury. Mol Cells 2018;41:93-102. [PMID: 29429150 DOI: 10.14348/molcells.2018.2163] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
83 Wakasugi H, Takahashi H, Niinuma T, Kitajima H, Oikawa R, Matsumoto N, Takeba Y, Otsubo T, Takagi M, Ariizumi Y, Suzuki M, Okuse C, Iwabuchi S, Nakano M, Akutsu N, Kang JH, Matsui T, Yamada N, Sasaki H, Yamamoto E, Kai M, Sasaki Y, Sasaki S, Tanaka Y, Yotsuyanagi H, Tsutsumi T, Yamamoto H, Tokino T, Nakase H, Suzuki H, Itoh F. Dysregulation of miRNA in chronic hepatitis B is associated with hepatocellular carcinoma risk after nucleos(t)ide analogue treatment. Cancer Lett 2018;434:91-100. [PMID: 30026054 DOI: 10.1016/j.canlet.2018.07.019] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
84 Mizuguchi Y, Takizawa T, Yoshida H, Uchida E. Dysregulated miRNA in progression of hepatocellular carcinoma: A systematic review. Hepatol Res. 2016;46:391-406. [PMID: 26490438 DOI: 10.1111/hepr.12606] [Cited by in Crossref: 65] [Cited by in F6Publishing: 67] [Article Influence: 9.3] [Reference Citation Analysis]
85 Monastyrskaya K, Sánchez-Freire V, Hashemi Gheinani A, Klumpp DJ, Babiychuk EB, Draeger A, Burkhard FC. miR-199a-5p regulates urothelial permeability and may play a role in bladder pain syndrome. Am J Pathol 2013;182:431-48. [PMID: 23201090 DOI: 10.1016/j.ajpath.2012.10.020] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 3.6] [Reference Citation Analysis]
86 Huang H, Kovacs ME, Y. Aguilera K, Brekken RA. Collagen Signaling in Cancer. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. Elsevier; 2019. pp. 89-108. [DOI: 10.1016/b978-0-12-816435-8.00007-9] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
87 Lyra-González I, Flores-Fong LE, González-García I, Medina-Preciado D, Armendáriz-Borunda J. MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine. World J Hepatol 2015; 7(11): 1530-1540 [PMID: 26085912 DOI: 10.4254/wjh.v7.i11.1530] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.1] [Reference Citation Analysis]
88 Jinato T, Chuaypen N, Poomipak W, Praianantathavorn K, Makkoch J, Kiatbumrung R, Jampoka K, Tangkijvanich P, Payungporn S. Original Research: Analysis of hepatic microRNA alterations in response to hepatitis B virus infection and pegylated interferon alpha-2a treatment. Exp Biol Med (Maywood) 2016;241:1803-10. [PMID: 27190255 DOI: 10.1177/1535370216647184] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
89 Mourad L, El-Ahwany E, Zoheiry M, Abu-Taleb H, Hassan M, Ouf A, Rahim AA, Hassanien M, Zada S. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients. Cancer Biol Ther 2018;19:400-6. [PMID: 29333940 DOI: 10.1080/15384047.2018.1423922] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
90 Zhao Z, Zhao S, Luo L, Xiang Q, Zhu Z, Wang J, Liu Y, Luo J. miR-199b-5p-DDR1-ERK signalling axis suppresses prostate cancer metastasis via inhibiting epithelial-mesenchymal transition. Br J Cancer 2021;124:982-94. [PMID: 33239676 DOI: 10.1038/s41416-020-01187-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
91 Inyawilert W, Fu TY, Lin CT, Tang PC. MicroRNA-199a mediates mucin 1 expression in mouse uterus during implantation. Reprod Fertil Dev 2014;26:653-64. [PMID: 23759257 DOI: 10.1071/RD12097] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
92 Callegari E, Elamin BK, Sabbioni S, Gramantieri L, Negrini M. Role of microRNAs in hepatocellular carcinoma: a clinical perspective. Onco Targets Ther. 2013;6:1167-1178. [PMID: 24039437 DOI: 10.2147/ott.s36161] [Cited by in Crossref: 19] [Cited by in F6Publishing: 33] [Article Influence: 2.1] [Reference Citation Analysis]
93 Möbus S, Yang D, Yuan Q, Lüdtke TH, Balakrishnan A, Sgodda M, Rani B, Kispert A, Araúzo-bravo MJ, Vogel A, Manns MP, Ott M, Cantz T, Sharma AD. MicroRNA-199a-5p inhibition enhances the liver repopulation ability of human embryonic stem cell-derived hepatic cells. Journal of Hepatology 2015;62:101-10. [DOI: 10.1016/j.jhep.2014.08.016] [Cited by in Crossref: 29] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
94 Gao M, Duan L, Luo J, Zhang L, Lu X, Zhang Y, Zhang Z, Tu Z, Xu Y, Ren X, Ding K. Discovery and optimization of 3-(2-(Pyrazolo[1,5-a]pyrimidin-6-yl)ethynyl)benzamides as novel selective and orally bioavailable discoidin domain receptor 1 (DDR1) inhibitors. J Med Chem 2013;56:3281-95. [PMID: 23521020 DOI: 10.1021/jm301824k] [Cited by in Crossref: 96] [Cited by in F6Publishing: 83] [Article Influence: 10.7] [Reference Citation Analysis]
95 Raimondi L, Amodio N, Di Martino MT, Altomare E, Leotta M, Caracciolo D, Gullà A, Neri A, Taverna S, D'Aquila P, Alessandro R, Giordano A, Tagliaferri P, Tassone P. Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics: in vitro and in vivo anti-tumor activity. Oncotarget 2014;5:3039-54. [PMID: 24839982 DOI: 10.18632/oncotarget.1747] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 9.4] [Reference Citation Analysis]
96 Leitinger B. Discoidin domain receptor functions in physiological and pathological conditions. Int Rev Cell Mol Biol 2014;310:39-87. [PMID: 24725424 DOI: 10.1016/B978-0-12-800180-6.00002-5] [Cited by in Crossref: 169] [Cited by in F6Publishing: 111] [Article Influence: 21.1] [Reference Citation Analysis]
97 Cario M. DDR1 and DDR2 in skin. Cell Adh Migr 2018;12:386-93. [PMID: 29952722 DOI: 10.1080/19336918.2018.1485618] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
98 Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT. Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma. World J Gastroenterol 2012; 18(38): 5442-5453 [PMID: 23082062 DOI: 10.3748/wjg.v18.i38.5442] [Cited by in CrossRef: 72] [Cited by in F6Publishing: 77] [Article Influence: 7.2] [Reference Citation Analysis]
99 Kim BK, Yoo HI, Kim I, Park J, Kim Yoon S. FZD6 expression is negatively regulated by miR-199a-5p in human colorectal cancer. BMB Rep 2015;48:360-6. [PMID: 25772759 DOI: 10.5483/bmbrep.2015.48.6.031] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
100 Zhang W, Zhang Q, Che L, Xie Z, Cai X, Gong L, Li Z, Liu D, Liu S. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer. BMC Cancer 2022;22:299. [PMID: 35313857 DOI: 10.1186/s12885-022-09281-1] [Reference Citation Analysis]
101 Wang Q, Yu X, Li Q, Qin L, Tan S, Zeng X, Qiu X, Tang B, Jin J, Liao W, Qiu M, Tan L, He G, Li X, He S, Yu H. Association between miR-199a rs74723057 and MET rs1621 polymorphisms and the risk of hepatocellular carcinoma. Oncotarget 2016;7:79365-71. [PMID: 27813498 DOI: 10.18632/oncotarget.13033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
102 Liu P, Xia P, Fu Q, Liu C, Luo Q, Cheng L, Yu P, Qin T, Zhang H. miR-199a-5p inhibits the proliferation of hepatocellular carcinoma cells by regulating CDC25A to induce cell cycle arrest. Biochem Biophys Res Commun 2021;571:96-103. [PMID: 34314996 DOI: 10.1016/j.bbrc.2021.07.035] [Reference Citation Analysis]
103 Duan Q, Wang X, Gong W, Ni L, Chen C, He X, Chen F, Yang L, Wang P, Wang DW. ER stress negatively modulates the expression of the miR-199a/214 cluster to regulates tumor survival and progression in human hepatocellular cancer. PLoS One 2012;7:e31518. [PMID: 22359598 DOI: 10.1371/journal.pone.0031518] [Cited by in Crossref: 101] [Cited by in F6Publishing: 104] [Article Influence: 10.1] [Reference Citation Analysis]
104 Jian Z, Sun J, Chen W, Jin H, Zheng J, Wu Y. Involvement of discoidin domain 1 receptor in recurrence of hepatocellular carcinoma by genome-wide analysis. Med Oncol 2012;29:3077-82. [DOI: 10.1007/s12032-012-0277-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
105 Bienertova-vasku J, Sana J, Slaby O. The role of microRNAs in mitochondria in cancer. Cancer Letters 2013;336:1-7. [DOI: 10.1016/j.canlet.2013.05.001] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 5.3] [Reference Citation Analysis]
106 Kong Y, Bai PS, Sun H, Nan KJ, Chen NZ, Qi XG. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer. Int J Biochem Cell Biol. 2012;44:2321-2332. [PMID: 22903020 DOI: 10.1016/j.biocel.2012.08.006] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
107 Yu X, He Y, Wang Y, Tang Y, Guo Y, Yuan J, Bai J, Yao T, Wu X. MicroRNA-199a-5p suppresses the cell growth of colorectal cancer by targeting oncogene Caprin1. 3 Biotech 2020;10:453. [PMID: 33088650 DOI: 10.1007/s13205-020-02433-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
108 Morita K, Shirabe K, Taketomi A, Soejima Y, Yoshizumi T, Uchiyama H, Ikegami T, Yamashita Y, Sugimachi K, Harimoto N, Itoh S, Ikeda T, Maehara Y. Relevance of microRNA-18a and microRNA-199a-5p to hepatocellular carcinoma recurrence after living donor liver transplantation: MIR-18A and MIR-199A-5P in HCC Recurrence. Liver Transpl 2016;22:665-76. [DOI: 10.1002/lt.24400] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 3.3] [Reference Citation Analysis]
109 Xu LJ, Duan Y, Wang P, Yin HQ. MiR-199b-5p promotes tumor growth and metastasis in cervical cancer by down-regulating KLK10. Biochem Biophys Res Commun 2018;503:556-63. [PMID: 29807015 DOI: 10.1016/j.bbrc.2018.05.165] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
110 Hu Y, Liu J, Jiang B, Chen J, Fu Z, Bai F, Jiang J, Tang Z. MiR-199a-5p loss up-regulated DDR1 aggravated colorectal cancer by activating epithelial-to-mesenchymal transition related signaling. Dig Dis Sci 2014;59:2163-72. [PMID: 24711074 DOI: 10.1007/s10620-014-3136-0] [Cited by in Crossref: 57] [Cited by in F6Publishing: 56] [Article Influence: 7.1] [Reference Citation Analysis]
111 Park JW, Lee YS, Kim JS, Lee SK, Kim BH, Lee JA, Lee NO, Kim SH, Hong EK. Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma. J Cancer Res Clin Oncol. 2015;141:1973-1983. [PMID: 25842034 DOI: 10.1007/s00432-015-1967-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
112 Sadri Nahand J, Bokharaei-Salim F, Salmaninejad A, Nesaei A, Mohajeri F, Moshtzan A, Tabibzadeh A, Karimzadeh M, Moghoofei M, Marjani A, Yaghoubi S, Keyvani H. microRNAs: Key players in virus-associated hepatocellular carcinoma. J Cell Physiol 2019;234:12188-225. [PMID: 30536673 DOI: 10.1002/jcp.27956] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 6.5] [Reference Citation Analysis]
113 Deng Y, Zhao F, Hui L, Li X, Zhang D, Lin W, Chen Z, Ning Y. Suppressing miR-199a-3p by promoter methylation contributes to tumor aggressiveness and cisplatin resistance of ovarian cancer through promoting DDR1 expression. J Ovarian Res 2017;10:50. [PMID: 28743276 DOI: 10.1186/s13048-017-0333-4] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 8.4] [Reference Citation Analysis]
114 Kim BK, Kim I, Yoon SK. Identification of miR-199a-5p target genes in the skin keratinocyte and their expression in cutaneous squamous cell carcinoma. J Dermatol Sci 2015;79:137-47. [PMID: 26026896 DOI: 10.1016/j.jdermsci.2015.05.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
115 Ezzoukhry Z, Henriet E, Piquet L, Boyé K, Bioulac-sage P, Balabaud C, Couchy G, Zucman-rossi J, Moreau V, Saltel F. TGF-β1 promotes linear invadosome formation in hepatocellular carcinoma cells, through DDR1 up-regulation and collagen I cross-linking. European Journal of Cell Biology 2016;95:503-12. [DOI: 10.1016/j.ejcb.2016.09.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
116 Li B, He L, Zuo D, He W, Wang Y, Zhang Y, Liu W, Yuan Y. Mutual Regulation of MiR-199a-5p and HIF-1α Modulates the Warburg Effect in Hepatocellular Carcinoma. J Cancer 2017;8:940-9. [PMID: 28529605 DOI: 10.7150/jca.17496] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
117 Dai B, Qiao L, Zhang M, Cheng L, Zhang L, Geng L, Shi C, Zhang M, Sui C, Shen W, Sun Y, Chen Q, Hui D, Wang Y, Yang J. lncRNA AK054386 Functions as a ceRNA to Sequester miR-199 and Induce Sustained Endoplasmic Reticulum Stress in Hepatic Reperfusion Injury. Oxid Med Cell Longev 2019;2019:8189079. [PMID: 31827704 DOI: 10.1155/2019/8189079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
118 Huo Y, Yang M, Liu W, Yang J, Fu X, Liu D, Li J, Zhang J, Hua R, Sun Y. High expression of DDR1 is associated with the poor prognosis in Chinese patients with pancreatic ductal adenocarcinoma. J Exp Clin Cancer Res 2015;34:88. [PMID: 26297342 DOI: 10.1186/s13046-015-0202-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
119 Su SF, Chang YW, Andreu-Vieyra C, Fang JY, Yang Z, Han B, Lee AS, Liang G. miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer. Oncogene 2013;32:4694-701. [PMID: 23085757 DOI: 10.1038/onc.2012.483] [Cited by in Crossref: 84] [Cited by in F6Publishing: 83] [Article Influence: 8.4] [Reference Citation Analysis]
120 Nada H, Lee K, Gotina L, Pae AN, Elkamhawy A. Identification of novel discoidin domain receptor 1 (DDR1) inhibitors using E-pharmacophore modeling, structure-based virtual screening, molecular dynamics simulation and MM-GBSA approaches. Comput Biol Med 2022;142:105217. [PMID: 35032738 DOI: 10.1016/j.compbiomed.2022.105217] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
121 Sun L, Zhu J, Wu M, Sun H, Zhou C, Fu L, Xu C, Mei C. Inhibition of MiR-199a-5p reduced cell proliferation in autosomal dominant polycystic kidney disease through targeting CDKN1C. Med Sci Monit 2015;21:195-200. [PMID: 25588980 DOI: 10.12659/MSM.892141] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
122 Chill HH, Dior UP, Kogan L, Revel A. microRNAs and Endometrial Pathophysiology. Adv Exp Med Biol 2015;887:143-55. [PMID: 26662990 DOI: 10.1007/978-3-319-22380-3_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
123 Gu S, Chan WY. Flexible and versatile as a chameleon-sophisticated functions of microRNA-199a. Int J Mol Sci 2012;13:8449-66. [PMID: 22942713 DOI: 10.3390/ijms13078449] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 4.1] [Reference Citation Analysis]
124 Elamin BK, Callegari E, Gramantieri L, Sabbioni S, Negrini M. MicroRNA response to environmental mutagens in liver. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2011;717:67-76. [DOI: 10.1016/j.mrfmmm.2011.03.015] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
125 Chiu LY, Kishnani PS, Chuang TP, Tang CY, Liu CY, Bali D, Koeberl D, Austin S, Boyette K, Weinstein DA. Identification of differentially expressed microRNAs in human hepatocellular adenoma associated with type I glycogen storage disease: a potential utility as biomarkers. J Gastroenterol. 2014;49:1274-1284. [PMID: 24129885 DOI: 10.1007/s00535-013-0890-2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
126 Elhefnawi M, Salah Z, Soliman B. The Promise of miRNA Replacement Therapy for Hepatocellular Carcinoma. CGT 2019;19:290-304. [DOI: 10.2174/1566523219666191023101433] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
127 Huang W, Huang F, Feng C. CircFoxo3 Promotes Adriamycin Resistance Through Regulation of miR-199a-5p/ATP Binding Cassette Subfamily C Member 1 Axis in Hepatocellular Carcinoma. Onco Targets Ther 2020;13:5113-22. [PMID: 32606732 DOI: 10.2147/OTT.S243571] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
128 Wahid B, Ali A, Rafique S, Idrees M. New Insights into the Epigenetics of Hepatocellular Carcinoma. Biomed Res Int 2017;2017:1609575. [PMID: 28401148 DOI: 10.1155/2017/1609575] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
129 Jing H, Song J, Zheng J. Discoidin domain receptor 1: New star in cancer-targeted therapy and its complex role in breast carcinoma. Oncol Lett 2018;15:3403-8. [PMID: 29467865 DOI: 10.3892/ol.2018.7795] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
130 Yuge R, Kitadai Y, Takigawa H, Naito T, Oue N, Yasui W, Tanaka S, Chayama K. Silencing of Discoidin Domain Receptor-1 (DDR1) Concurrently Inhibits Multiple Steps of Metastasis Cascade in Gastric Cancer. Transl Oncol 2018;11:575-84. [PMID: 29547756 DOI: 10.1016/j.tranon.2018.02.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
131 Soliman B, Salem A, Ghazy M, Abu-Shahba N, El Hefnawi M. Bioinformatics functional analysis of let-7a, miR-34a, and miR-199a/b reveals novel insights into immune system pathways and cancer hallmarks for hepatocellular carcinoma. Tumour Biol 2018;40:1010428318773675. [PMID: 29775159 DOI: 10.1177/1010428318773675] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
132 Chung VY, Tan TZ, Huang RL, Lai HC, Huang RY. Loss of discoidin domain receptor 1 (DDR1) via CpG methylation during EMT in epithelial ovarian cancer. Gene 2017;635:9-15. [PMID: 28887161 DOI: 10.1016/j.gene.2017.09.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
133 Çil N, Yaka M, Ünal MS, Dodurga Y, Tan S, Seçme M, Karagür ER, Mete GA. Adipose derived mesenchymal stem cell treatment in experimental asherman syndrome induced rats. Mol Biol Rep 2020;47:4541-52. [DOI: 10.1007/s11033-020-05505-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
134 El-abd NE, Fawzy NA, El-sheikh SM, Soliman ME. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection. Mol Diagn Ther 2015;19:213-20. [DOI: 10.1007/s40291-015-0148-1] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 6.7] [Reference Citation Analysis]
135 Wang P, Chen S, Fang H, Wu X, Chen D, Peng L, Gao Z, Xie C. miR-214/199a/199a* cluster levels predict poor survival in hepatocellular carcinoma through interference with cell-cycle regulators. Oncotarget 2016;7:929-45. [PMID: 26498144 DOI: 10.18632/oncotarget.6137] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
136 Felgendreff P, Raschzok N, Kunze K, Leder A, Lippert S, Klunk S, Tautenhahn H, Hau H, Schmuck RB, Reutzel-selke A, Sauer IM, Bartels M, Morgül MH. Tissue-based miRNA mapping in alcoholic liver cirrhosis: different profiles in cirrhosis with or without hepatocellular carcinoma. Biomarkers 2020;25:62-8. [DOI: 10.1080/1354750x.2019.1691267] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
137 Li Y, Lu X, Ren X, Ding K. Small Molecule Discoidin Domain Receptor Kinase Inhibitors and Potential Medical Applications: Miniperspective. J Med Chem 2015;58:3287-301. [DOI: 10.1021/jm5012319] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 6.0] [Reference Citation Analysis]
138 Wang W, Zhao LJ, Tan YX, Ren H, Qi ZT. MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma. Carcinogenesis 2012;33:1113-20. [PMID: 22362728 DOI: 10.1093/carcin/bgs113] [Cited by in Crossref: 153] [Cited by in F6Publishing: 141] [Article Influence: 15.3] [Reference Citation Analysis]
139 Lu QP, Chen WD, Peng JR, Xu YD, Cai Q, Feng GK, Ding K, Zhu XF, Guan Z. Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells. Oncol Lett 2016;12:3598-608. [PMID: 27900042 DOI: 10.3892/ol.2016.5088] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]